Trial Profile
A Phase III Study of P-4 to Investigate Overactive Bladder
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Nov 2022
Price :
$35
*
At a glance
- Drugs Propiverine (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 01 Jun 2016 New trial record